NEWS RELEASE
Duis autem vel eum iriure dolor in ss hendrerit in vulputate velit esse fdas molestie consequatgdsfdasfdsaffse Duis autem vel eum iriure dolor in ss hendrerit in vulputate velit esse fdas
Amarin Reports Second Quarter 2022 Financial Results and Provides Business Update
Company Received Final Positive Reimbursement Decision for VAZKEPA ® by UK’s NICE in England & Wales Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Initiated Comprehensive Cost Reduction Plan in June to Address Market Dynamics in the U.S.